Ratings
0
Nobody has rated this yet. Be the first!
Works
2
Standard operating procedure for curation and clinical interpretation of variants in cancer
Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors.
